## JOANNA YI

| | Title| Assistant Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Pediatrics  
Address| 1102 BATES  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=HKQx72vGbrL8Zo3u7TXHLqE%3d&rnd=5f498b2f-6206-49ce-b288-1c42d070c3f7)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=15317815)  
  
![](https://profiles.viictr.org/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx?NodeID=15317815&cachekey=7a67daa7-51cb-4067-a15b-2a837d2c47d0)  
  

  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Biography  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
education and training

Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA| | 06/2013| Pediatric Hematology/Oncology  
---|---|---|---  
University of Minnesota Pediatrics Department, Minneapolis, MN| | 06/2010| Pediatrics Residency  
University of Wisconsin-Madison School of Medicine and Public Health, Madison,
WI| MD| 05/2007| Medicine  
University of Wisconsin-Madison, Madison, WI| BS| 05/2003|
Pharmacology/Toxicology  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
awards and honors

2008 - 2008| Norma K. C. Ramsey Award of Excellence for the Most Outstanding
Resident in Pediatric Heme/Onc/BMT, University of Minnesota Pediatrics
Department  
---|---  
2010 - 2010| Susan Vincent Outstanding Resident Teaching Award, University of
Minnesota Pediatrics Department  
2012 - 2017| Loan Repayment Program, NIH  
2014 - 2014| Abstract Achievement Award, American Society of Hematology  
2018 - 2018| Methods in Clinical Cancer Research Vail Workshop, AACR/ASCO  
2023 - 2023| Star Award for Excellence in Patient Care, Baylor College of
Medicine  
2023 - 2023| TXCH Faculty Education Award, Texas Children's Cancer and
Hematology Centers  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Overview  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
overview

Dr. Joanna Yi is a member of Texas Children's Cancer Center's Developmental
Therapeutics and Leukemia Teams. Her translational research focuses on the
pre-clinical identification and development of new, targeted small molecules
for the treatment of childhood cancers with the purpose of evaluating them in
early phase clinical trials. She is especially interested in epigenetic drugs
and combining them with other active agents.  
  
Dr. Yi wants to discover new, less toxic, targeted drugs by combining the
translational drug discovery techniques of the Center for Drug Discovery at
Baylor College of Medicine, with the clinical developmental therapeutics
program of Texas Children’s Cancer and Hematology Centers. In the laboratory,
Dr. Yi is working with TCH and BCM investigators in the cancer center to
identify and characterize small molecules with clinical promise in challenging
pediatric cancers. She also is developing tests of “on-target” effect of these
compounds to be used in clinical trials and evaluating the targeted small
molecules in combination with other active agents to identify the best
combinations to move forwards to clinical trials. Her lab is also studying the
transcriptional control of pediatric leukemias to find new, druggable targets.  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
keywords

  * [drug discovery](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=drug discovery&exactphrase=false)
  * [pediatric leukemia](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=pediatric leukemia&exactphrase=false)
  * [early phase clinical trials](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=early phase clinical trials&exactphrase=false)
  * [chromatin](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=chromatin&exactphrase=false)
  * [epigenetic](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=epigenetic&exactphrase=false)
  * [targeted small molecules](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=targeted small molecules&exactphrase=false)
  * [Pediatric oncology](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=Pediatric oncology&exactphrase=false)

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
webpage  
  
![](https://www.google.com/s2/favicons?domain=http://www.texaschildrens.org/find-
a-doctor/joanna-s-yi-md)| [Texas Children's
profile](http://www.texaschildrens.org/find-a-doctor/joanna-s-yi-md)  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. Buteyn NJ, Burke CG, Sartori VJ, Deering-Gardner E, DeBruine ZJ, Kamarudin D, Chandler DP, Monovich AC, Perez MW, **Yi JS** , Ries RE, Alonzo TA, Ryan RJ, Meshinchi S, Triche TJ, Buteyn NJ, Burke CG, Sartori VJ, Deering-Gardner E, DeBruine ZJ, Kamarudin D, Chandler DP, Monovich AC, Perez MW, Yi JS, Ries RE, Alonzo TA, Ryan RJ, Meshinchi S, Triche TJ. EZH2-driven immune evasion defines high-risk pediatric AML with t(16;21) FUS::ERG gene fusion. bioRxiv. 2024 Jun 25. PMID: [38798454](//www.ncbi.nlm.nih.gov/pubmed/38798454); PMCID: [PMC11118270](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11118270).

Citations:

  2. Williams PM, Patton DR, Coffey BD, Reid JM, Piao J, Alonzo TA, [Berg SL](https://profiles.viictr.org/profile/266981), Ramirez NC, Jaju A, Fox E, Takebe N, Tricoli JV, Janeway KA, [Parsons DW](https://profiles.viictr.org/profile/265886), Chi SN, **Yi JS** , Roy-Chowdhuri S, Saguilig L, Mhlanga JC, Hawkins DS, Mooney MM, Seibel NL. Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C. J Natl Cancer Inst. 2023 11 08; 115(11):1355-1363. PMID: [37228094](//www.ncbi.nlm.nih.gov/pubmed/37228094); PMCID: [PMC11009504](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11009504).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37228094/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  3. Trabal A, Gibson A, He J, McCall D, Roth M, Nu?ez C, Garcia M, Buzbee M, Toepfer L, Bidikian A, [Daver N](https://profiles.viictr.org/profile/12583574), [Kadia T](https://profiles.viictr.org/profile/12583065), Short NJ, Issa GC, Ravandi F, [DiNardo CD](https://profiles.viictr.org/profile/12583624), Montalban Bravo G, Garces S, [Marcogliese A](https://profiles.viictr.org/profile/266792), [Paek H](https://profiles.viictr.org/profile/30445271), Dreyer Z, [Brackett J](https://profiles.viictr.org/profile/265632), [Redell M](https://profiles.viictr.org/profile/269414), **Yi J** , [Garcia-Manero G](https://profiles.viictr.org/profile/12583738), [Konopleva M](https://profiles.viictr.org/profile/12583701), [Stevens A](https://profiles.viictr.org/profile/1826717), Cuglievan B. Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience. Cancers (Basel). 2023 Mar 26; 15(7). PMID: [37046645](//www.ncbi.nlm.nih.gov/pubmed/37046645); PMCID: [PMC10093646](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10093646).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37046645/citedby/)

  4. Modukuri RK, Yu Z, [Tan Z](https://profiles.viictr.org/profile/32901598), Ta HM, Ucisik MN, Jin Z, Anglin JL, [Sharma KL](https://profiles.viictr.org/profile/37476693), Nyshadham P, Li F, Riehle K, Faver JC, [Duong K](https://profiles.viictr.org/profile/47100898), Nagarajan S, Simmons N, Palmer SS, [Teng M](https://profiles.viictr.org/profile/36751796), [Young DW](https://profiles.viictr.org/profile/5099690), **Yi JS** , Kim C, [Matzuk MM](https://profiles.viictr.org/profile/266520). Discovery of potent BET bromodomain 1 stereoselective inhibitors using DNA-encoded chemical library selections. Proc Natl Acad Sci U S A. 2022 05 31; 119(22):e2122506119. PMID: [35622893](//www.ncbi.nlm.nih.gov/pubmed/35622893); PMCID: [PMC9295786](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9295786).

Citations:  Fields:

Sci Science

Translation:HumansCells

  5. **Yi JS** , Chambers TM, Getz KD, Miller TP, Burrows E, Daves MH, [Lupo PJ](https://profiles.viictr.org/profile/270034), [Scheurer ME](https://profiles.viictr.org/profile/265805), Aplenc R, [Rabin KR](https://profiles.viictr.org/profile/265501), [Gramatges MM](https://profiles.viictr.org/profile/266349). A report from the Leukemia Electronic Abstraction of Records Network on risk of hepatotoxicity during pediatric acute lymphoblastic leukemia treatment. Haematologica. 2022 05 01; 107(5):1185-1188. PMID: [35081687](//www.ncbi.nlm.nih.gov/pubmed/35081687); PMCID: [PMC9052928](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9052928).

Citations:  Fields:

Hem Hematology

Translation:Humans

  6. Sharma S, Hourigan B, Patel Z, Rosenfeld JA, Chan KM, [Wangler MF](https://profiles.viictr.org/profile/268429), **Yi JS** , Lehman A, CAUSES Study, Horvath G, Cloos PA, Tan Q. Novel CIC variants identified in individuals with neurodevelopmental phenotypes. Hum Mutat. 2022 07; 43(7):889-899. PMID: [35165976](//www.ncbi.nlm.nih.gov/pubmed/35165976).

Citations:  Fields:

Gen Genetics

Translation:Humans

  7. Harada T, Heshmati Y, Perez MW, Xavier Ferrucio J, Ewers J, Hubbell Engler B, Kossenkov A, Ellegast JM, **Yi JS** , Bowker A, Zhu Q, Eagle K, Liu T, Kai Y, Dempster JM, Kugener G, Wickramasinghe J, Herbert ZT, Li CH, Weinstock DM, Paralkar VR, Nabet B, Lin CY, Dharia NV, Stegmaier K, Orkin SH, Pimkin M, Kalfon J, Vrabic Koren J. A distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemia. Genes Dev. 2022 03 01; 36(5-6):368-389. PMID: [35301220](//www.ncbi.nlm.nih.gov/pubmed/35301220); PMCID: [PMC8973843](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8973843).

Citations:  Fields:

Mol Molecular Biology

Translation:Humans

  8. Eagle K, Jiang Y, Shi X, Li M, Obholzer NP, Hu T, Perez MW, Kitano A, **Yi JS** , Lin CY, [Nakada D](https://profiles.viictr.org/profile/268530), Koren JV. An oncogenic enhancer encodes selective selenium dependency in AML. Cell Stem Cell. 2022 03 03; 29(3):386-399.e7. PMID: [35108519](//www.ncbi.nlm.nih.gov/pubmed/35108519); PMCID: [PMC8903199](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8903199).

Citations:  Fields:

Cel Cell Biology

Translation:HumansAnimalsCells

  9. O'Brien MM, Ji L, Shah NN, Rheingold SR, Bhojwani D, Yuan CM, Xu X, **Yi JS** , Harris AC, Brown PA, Borowitz MJ, Militano O, Kairalla J, Devidas M, Raetz EA, Gore L, Loh ML. Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621. J Clin Oncol. 2022 03 20; 40(9):956-967. PMID: [35007127](//www.ncbi.nlm.nih.gov/pubmed/35007127); PMCID: [PMC8937013](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8937013).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/35007127/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  10. Perez MW, Sias-Garcia O, Daramola A, Wei H, Terrell M, Rashid R, Park WD, [Duong K](https://profiles.viictr.org/profile/47100898), [Horton TM](https://profiles.viictr.org/profile/266755), Li F, Cherayil N, Koren JV, Gant VU, Junco JJ, [Curry CV](https://profiles.viictr.org/profile/268836), Stevens AM, Lin CY, **Yi JS**. Defining the transcriptional control of pediatric AML highlights RARA as a superenhancer-regulated druggable dependency. Blood Adv. 2021 12 14; 5(23):4864-4876. PMID: [34543389](//www.ncbi.nlm.nih.gov/pubmed/34543389); PMCID: [PMC9153032](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9153032).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34543389/citedby/) Fields:

Hem Hematology

Translation:HumansAnimals

  11. McCall D, Roth M, Mahadeo KM, Toepfer L, [Nunez C](https://profiles.viictr.org/profile/12583325), Short NJ, [Daver N](https://profiles.viictr.org/profile/12583574), [Kadia TM](https://profiles.viictr.org/profile/12583065), [DiNardo C](https://profiles.viictr.org/profile/12583624), **Yi JS** , Cuglievan B. Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia. Blood Adv. 2021 12 14; 5(23):5215-5219. PMID: [34592761](//www.ncbi.nlm.nih.gov/pubmed/34592761); PMCID: [PMC9153013](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9153013).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34592761/citedby/) Fields:

Hem Hematology

Translation:Humans

  12. **Yi JS** , Sias-Garcia O, Nasholm N, Hu X, Iniguez AB, Hall MD, Davis M, Guha R, Moreno-Smith M, [Barbieri E](https://profiles.viictr.org/profile/270157), [Duong K](https://profiles.viictr.org/profile/47100898), Koach J, Qi J, Bradner JE, Stegmaier K, Weiss WA, Gustafson WC. The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53. Neoplasia. 2021 06; 23(6):624-633. PMID: [34107377](//www.ncbi.nlm.nih.gov/pubmed/34107377); PMCID: [PMC8192452](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8192452).

Citations:  Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  13. Arabzade A, Zhao Y, Varadharajan S, Chen HC, Jessa S, Rivas B, Stuckert AJ, Solis M, [Kardian A](https://profiles.viictr.org/profile/28999343), Tlais D, Golbourn BJ, Stanton AJ, Chan YS, Olson C, [Karlin KL](https://profiles.viictr.org/profile/1826677), Kong K, Kupp R, Hu B, Injac SG, Ngo M, Wang PR, Sahm F, Kawauchi D, Pfister SM, Lin CY, Hodges HC, Singh I, [Westbrook TF](https://profiles.viictr.org/profile/267742), [Chintagumpala MM](https://profiles.viictr.org/profile/268049), [Blaney SM](https://profiles.viictr.org/profile/268174), [Parsons DW](https://profiles.viictr.org/profile/265886), Pajtler KW, Agnihotri S, Gilbertson RJ, **Yi J** , Jabado N, Kleinman CL, Bertrand KC, [Deneen B](https://profiles.viictr.org/profile/266334), Mack SC, De Le?n LA. ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma. Cancer Discov. 2021 09; 11(9):2200-2215. PMID: [33741710](//www.ncbi.nlm.nih.gov/pubmed/33741710); PMCID: [PMC8418998](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8418998).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33741710/citedby/) Fields:

Neo Neoplasms

Translation:Animals

  14. Pearson AD, DuBois SG, Buenger V, Kieran M, Stegmaier K, Bandopadhayay P, Bennett K, Bourdeaut F, Brown PA, Chesler L, Clymer J, Fox E, French CA, Germovsek E, Giles FJ, Bender JG, Hattersley MM, Ludwinski D, Luptakova K, Maris J, McDonough J, Nikolova Z, Smith M, Tsiatis AC, Vibhakar R, Weiner S, **Yi JS** , Zheng F, Vassal G. Bromodomain and extra-terminal?inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE. Eur J Cancer. 2021 03; 146:115-124. PMID: [33601323](//www.ncbi.nlm.nih.gov/pubmed/33601323).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33601323/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  15. Chen Z, Zhao Y, Yu Y, Pang JC, [Woodfield SE](https://profiles.viictr.org/profile/15317927), Tao L, Guan S, Zhang H, Bieerkehazhi S, Shi Y, Patel R, [Vasudevan SA](https://profiles.viictr.org/profile/269879), **Yi JS** , Muscal JA, Xu GT, Yang J. Small molecule inhibitor regorafenib inhibits RET signaling in neuroblastoma cells and effectively suppresses tumor growth in vivo. Oncotarget. 2017 Nov 28; 8(61):104090-104103. PMID: [29262623](//www.ncbi.nlm.nih.gov/pubmed/29262623); PMCID: [PMC5732789](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5732789).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29262623/citedby/) Fields:

Neo Neoplasms

  16. Bieerkehazhi S, Chen Z, Zhao Y, Yu Y, Zhang H, [Vasudevan SA](https://profiles.viictr.org/profile/269879), [Woodfield SE](https://profiles.viictr.org/profile/15317927), Tao L, **Yi JS** , Muscal JA, Pang JC, Guan S, Zhang H, [Nuchtern JG](https://profiles.viictr.org/profile/266271), Li H, Li H, Yang J. Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling. Oncotarget. 2017 Jan 03; 8(1):1469-1480. PMID: [27903968](//www.ncbi.nlm.nih.gov/pubmed/27903968); PMCID: [PMC5352070](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5352070).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27903968/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  17. Lu J, Guan S, Zhao Y, Yu Y, Wang Y, Shi Y, Mao X, Yang KL, Sun W, Xu X, **Yi JS** , Yang T, Yang J, [Nuchtern JG](https://profiles.viictr.org/profile/266271). Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastoma. Oncotarget. 2016 Dec 13; 7(50):82757-82769. PMID: [27764791](//www.ncbi.nlm.nih.gov/pubmed/27764791); PMCID: [PMC5347730](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5347730).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27764791/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  18. **Yi JS** , Kamihara J, Kesselheim JC, Davies K, van Hoff J, Silverman LB, Mullen EA. Synchronous occurrence of acute lymphoblastic leukemia and wilms tumor in two patients: underlying etiology and combined treatment plan. Pediatr Blood Cancer. 2017 05; 64(5). PMID: [27862952](//www.ncbi.nlm.nih.gov/pubmed/27862952).

Citations:  Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:Humans

  19. Chen Z, Wang Z, Pang JC, Yu Y, Bieerkehazhi S, Lu J, Hu T, Zhao Y, Xu X, Zhang H, **Yi JS** , Liu S, Yang J. Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity. Sci Rep. 2016 07 05; 6:29090. PMID: [27378523](//www.ncbi.nlm.nih.gov/pubmed/27378523); PMCID: [PMC4932496](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4932496).

Citations:
[35](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27378523/citedby/) Fields:

Sci Science

Translation:HumansAnimalsCells

  20. Green AL, **Yi J** , Bezler N, Pikman Y, Obeng EA, O'Neil T, Mersereau R, Morrissey L, Billett AL, [Tubman VN](https://profiles.viictr.org/profile/20424276). A Prospective Cohort Quality Improvement Study to Reduce the Time to Antibiotics for New Fever in Neutropenic Pediatric Oncology Inpatients. Pediatr Blood Cancer. 2016 Jan; 63(1):112-7. PMID: [26292080](//www.ncbi.nlm.nih.gov/pubmed/26292080).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26292080/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:Humans

  21. Dhe-Paganon S, Hadler M, Xu X, Wu L, Armstrong SA, **Yi JS** , Federation AJ, Qi J, St Pierre R, Varca AC, Marineau JJ, Smith WB, Souza A, Chory EJ, Bradner JE. Structure-guided DOT1L probe optimization by label-free ligand displacement. ACS Chem Biol. 2015 Mar 20; 10(3):667-74. PMID: [25397901](//www.ncbi.nlm.nih.gov/pubmed/25397901); PMCID: [PMC4504433](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4504433).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25397901/citedby/) Fields:

Bio BiochemistryBio Biology

Translation:HumansCells

  22. **Yi JS** , Hall BA, Moertel CL, Fritch Lilla SA. A novel APC gene mutation associated with a severe phenotype in a patient with Turcot syndrome. J Pediatr Hematol Oncol. 2014 Apr; 36(3):e177-9. PMID: [24309598](//www.ncbi.nlm.nih.gov/pubmed/24309598).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24309598/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:Humans

  23. Yu W, Chory EJ, Wernimont AK, Tempel W, Scopton A, Federation A, Marineau JJ, Qi J, Barsyte-Lovejoy D, **Yi J** , Marcellus R, Iacob RE, Engen JR, Griffin C, Aman A, Wienholds E, Li F, Pineda J, Estiu G, Shatseva T, Hajian T, Al-Awar R, Dick JE, Vedadi M, Brown PJ, Arrowsmith CH, Bradner JE, Schapira M. Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors. Nat Commun. 2012; 3:1288. PMID: [23250418](//www.ncbi.nlm.nih.gov/pubmed/23250418).

Citations:
[129](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23250418/citedby/)
Fields:

Bio BiologySci Science

Translation:HumansCells

  24. **Yi JS** , Moertel CL, Baker KS. Homozygous alpha-thalassemia treated with intrauterine transfusions and unrelated donor hematopoietic cell transplantation. J Pediatr. 2009 May; 154(5):766-8. PMID: [19364562](//www.ncbi.nlm.nih.gov/pubmed/19364562).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19364562/citedby/) Fields:

Ped Pediatrics

Translation:Humans

  25. Serra A, Brozoski D, Simeon T, **Yi J** , Bastasic J, Franciosi R, Jacobs ER, Forster HV. Serotonin and serotonin receptor expression in the aorta of carotid intact and denervated newborns. Respir Physiol Neurobiol. 2002 Sep 04; 132(3):253-64. PMID: [12208084](//www.ncbi.nlm.nih.gov/pubmed/12208084).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12208084/citedby/) Fields:

Pul Pulmonary Medicine

Translation:Animals

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 25 publications over 11 distinct years, with a maximum of
6 publications in
2022](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|6&cht=bvs&chd=t:0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,17,0,0,17,0,17,33,50,33,0,0,0,83,100,33,17&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
2002| 1  
2009| 1  
2012| 1  
2014| 1  
2015| 2  
2016| 3  
2017| 2  
2021| 5  
2022| 6  
2023| 2  
2024| 1  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

YI's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (164)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Neuroblastoma](https://profiles.viictr.org/profile/264265)
  * [N-Myc Proto-Oncogene Protein](https://profiles.viictr.org/profile/27544916)
  * [Chemical and Drug Induced Liver Injury](https://profiles.viictr.org/profile/253268)
  * [Aurora Kinase A](https://profiles.viictr.org/profile/27547103)
  * [Gene Amplification](https://profiles.viictr.org/profile/243789)

[Explore](https://profiles.viictr.org/profile/15317815/198)

_

Co-Authors (38)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [GRAMATGES, MARIA](https://profiles.viictr.org/profile/266349)
  * [DUONG, KEVIN](https://profiles.viictr.org/profile/47100898)
  * [MATZUK, MARTIN](https://profiles.viictr.org/profile/266520)
  * [RABIN, KAREN](https://profiles.viictr.org/profile/265501)
  * [SCHEURER, MICHAEL](https://profiles.viictr.org/profile/265805)

[Explore](https://profiles.viictr.org/profile/15317815/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [KANTARJIAN, HAGOP M](https://profiles.viictr.org/profile/12582901)
  * [JABBOUR, ELIAS JOSEPH](https://profiles.viictr.org/profile/12583425)
  * [CORTES, JORGE E](https://profiles.viictr.org/profile/12582539)
  * [KONOPLEVA, MARINA](https://profiles.viictr.org/profile/12583701)
  * [GARCIA-MANERO, GUILLERMO](https://profiles.viictr.org/profile/12583738)

[Explore](https://profiles.viictr.org/profile/15317815/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [CONNEELY, SHANNON](https://profiles.viictr.org/profile/17822544)
  * [FETZKO, STEPHANIE](https://profiles.viictr.org/profile/15317838)
  * [GRUNER, STEPHANIE](https://profiles.viictr.org/profile/269355)
  * [HORTON, TERZAH](https://profiles.viictr.org/profile/266755)
  * [RITTER, DEBORAH](https://profiles.viictr.org/profile/3009521)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=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)

_

